Estimating regional and national cancer incidence in Uganda: a retrospective population-based study, 2013-2017

被引:0
作者
Nakaganda, Annet [1 ,2 ]
Spencer, Angela [2 ]
Mpamani, Collins [1 ]
Nassolo, Cissy [1 ]
Nambooze, Sarah [3 ,4 ]
Wabinga, Henry [3 ,4 ]
Gemmell, Isla [2 ]
Jones, Andrew [2 ]
Orem, Jackson [1 ]
Verma, Arpana [2 ]
机构
[1] Uganda Canc Inst, Kampala, Uganda
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, England
[3] Kampala Canc Registry, Kampala, Uganda
[4] Makerere Univ, Coll Hlth Sci, Kampala, Uganda
关键词
Estimating; Regional; National; Cancer; Incidence; Surveillance; REGISTRATION; COUNTRIES; QUALITY;
D O I
10.1186/s12885-024-12543-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCancer is becoming a major health problem in Uganda. Cancer control requires accurate estimates of the cancer burden for planning and monitoring of the cancer control strategies. However, cancer estimates and trends for Uganda are mainly based on one population-based cancer registry (PBCR), located in Kampala, the capital city, due to a lack of PBCRs in other regions. This study aimed at estimating cancer incidence among the geographical regions and providing national estimates of cancer incidence in Uganda.MethodsA retrospective study, using a catchment population approach, was conducted from June 2019 to February 2020. The study registered all newly diagnosed cancer cases, in the period of 2013 to 2017, among three geographical regions: Central, Western and Eastern regions. Utilizing regions as strata, stratified random sampling was used to select the study populations. Cases were coded according to the International Classification of Diseases for Oncology (ICD-0-03). Data was analysed using CanReg5 and Microsoft Excel.Results11598 cases (5157 males and 6441 females) were recorded. The overall national age-standardized incidence rates (ASIR) were 82.9 and 87.4 per 100,000 people in males and females respectively. The regional ASIRs were: 125.4 per 100,000 in males and 134.6 per 100,000 in females in central region; 58.2 per 100,000 in males and 56.5 per 100,000 in females in Western region; and 46.5 per 100,000 in males and 53.7 per 100,000 in females in Eastern region. Overall, the most common cancers in males over the study period were cancers of the prostate, oesophagus, Kaposi's sarcoma, stomach and liver. In females, the most frequent cancers were: cervix, breast, oesophagus, Kaposi's sarcoma and stomach.ConclusionThe overall cancer incidence rates from this study are different from the documented national estimates for Uganda. This emphasises the need to enhance the current methodologies for describing the country's cancer burden. Studies like this one are critical in enhancing the cancer surveillance system by estimating regional and national cancer incidence and allowing for the planning and monitoring of evidence-based cancer control strategies at all levels.
引用
收藏
页数:11
相关论文
共 43 条
[1]  
[Anonymous], 2018, Uganda Demographic and Health Survey 2016
[2]   An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence [J].
Antoni, Sebastien ;
Soerjomataram, Isabelle ;
Moller, Bjorn ;
Bray, Freddie ;
Ferlay, Jacques .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (03) :174-184
[3]   Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period [J].
Baum, Christina ;
Soliman, Amr S. ;
Brown, Heidi E. ;
Seifeldin, Ibrahim A. ;
Ramadan, Mohamed ;
Lott, Breanne ;
Nguyen, An ;
El-Ghawalby, Ahmed ;
Hablas, Ahmed .
JOURNAL OF CANCER EPIDEMIOLOGY, 2020, 2020
[4]   Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Laversanne, Mathieu ;
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) :229-263
[5]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[6]   Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness [J].
Bray, Freddie ;
Parkin, D. Max .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) :747-755
[7]  
Budukh, 2018, INT J NONCOMMUN DIS, V3, P56, DOI DOI 10.4103/JNCD.JNCD_19_18
[8]   Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care [J].
Curado, Maria Paula ;
Voti, Lydia ;
Sortino-Rachou, Ana Maria .
CANCER CAUSES & CONTROL, 2009, 20 (05) :751-756
[9]  
Curado MP, 2005, EUR J CANCER PREV, V14, P307
[10]  
DosSantos Silva I., 1999, Cancer epidemiology: principles and methods